Financhill
Sell
31

BKYI Quote, Financials, Valuation and Earnings

Last price:
$0.89
Seasonality move :
9.58%
Day range:
$0.86 - $0.99
52-week range:
$0.52 - $4.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.18x
P/B ratio:
21.15x
Volume:
150.3K
Avg. volume:
112K
1-year change:
-67.97%
Market cap:
$2.8M
Revenue:
$7.8M
EPS (TTM):
-$6.13

Earnings Data

Next earnings date for BKYI
Apr 02
2025
Most recent earnings per share
-$0.39
Beat by $0.19
(Nov 15/2024)
Consensus Estimate
-$0.58
(Nov 15/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BKYI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2024 Q4 $2.3M -- -- -$0.35 --
11/15/2024 Q3 $1.6M $2.1M -$0.39 -$0.58 $0.19
08/15/2024 Q2 $2M $1.1M -$1.00 -$0.54 -$0.46
06/17/2024 Q1 -- $2.2M -$0.32 -- --
12/31/2023 Q4 -- $1.8M -$4.42 -- --
09/30/2023 Q3 -- -- -$3.22 -$4.32 $1.10
06/30/2023 Q2 -- -- -$4.71 -$3.24 -$1.47
03/31/2023 Q1 -- -- -$3.51 -$4.86 $1.35
12/31/2022 Q4 -- -- -$11.16 -$4.86 -$6.30
09/30/2022 Q3 -- -- -$5.22 -- --
06/30/2022 Q2 -- -- -$3.78 -- --
05/13/2022 Q1 -- -- -$2.34 -- --
12/31/2021 Q4 -- -- -$4.68 -- --
11/12/2021 Q3 -- -- -$2.34 -- --
08/13/2021 Q2 -- -- -$2.70 -- --
05/14/2021 Q1 -- -- -$1.98 -- --
03/09/2021 Q4 -- -- -$3.24 -- --
11/12/2020 Q3 -- -- -$9.18 -- --
08/14/2020 Q2 -- -- -$10.80 -- --
03/31/2020 Q1 -- -- -$33.12 -- --
12/31/2019 Q4 -- -- -$13.09 -- --
09/30/2019 Q3 -- -- -$18.72 -- --
06/30/2019 Q2 -- -- -$14.40 -- --
03/31/2019 Q1 -- -- -$18.72 -- --
12/31/2018 Q4 -- -- -$14.40 -- --
09/30/2018 Q3 -- -- -$33.12 -- --
06/30/2018 Q2 -- -- -$21.60 -- --
03/31/2018 Q1 -- -- -$43.20 -- --
03/29/2018 Q4 -- -- $5.76 -- --
09/30/2017 Q3 -- -- -$40.32 -- --
06/30/2017 Q2 -- -- -$46.08 -- --
03/31/2017 Q1 -- -- -$37.44 -- --
12/31/2016 Q4 -- -- -$17.28 -- --
09/30/2016 Q3 -- -- -$34.56 -- --
06/30/2016 Q2 -- -- -$41.76 -- --
03/31/2016 Q1 -- -- -$36.00 -- --
12/31/2015 Q4 -- -- -$17.28 -- --
09/30/2015 Q3 -- -- -$34.56 -- --
06/30/2015 Q2 -- -- $17.28 -- --
03/31/2015 Q1 -- -- -$17.28 -- --
12/31/2014 Q4 -- -- -$17.28 -- --

BIO-key International Earnings Questions

  • How Much did BIO-key International Generate in Revenue Last Quarter?

    BIO-key International reported $2.1M worth of top line sales in its most recent quarter.

  • Did BIO-key International Beat Earnings Last Quarter?

    BIO-key International announced earnings per share of -$0.39 which represents a beat of analyst forecast a -$0.58 per share.

  • Is BIO-key International Profitable?

    BIO-key International reported $1.7M that represents $0.89 per share over the last quarter.

  • What is the Analyst Consensus for BIO-key International EPS Next Year?

    BIO-key International's earnings are forecast to decrease from -$15.21 per share to -- per share next year representing a decrease of -87.77%.

  • When is BIO-key International's Earnings Date?

    BIO-key International's next earnings date is April 2, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock